Adam Connelly

Adam Connelly has a diverse work experience spanning over 17 years in the pharmaceutical industry. Adam is currently serving as the Director of Quality Control at Chroma Medicine since 2023. Prior to this, they worked at Leap Therapeutics as the Associate Director CMC Analytical Development & Quality Control, where they managed analytical development efforts for two clinical-phase molecules in the oncology space. Before Leap Therapeutics, Adam worked at Vertex Pharmaceuticals as a Senior Manager QA Analytical, and at Moderna as a Manager of the Quality Control Method Validation and Technical Transfer group. Adam also gained experience at Merrimack as a QC specialist and at Genzyme, a Sanofi company, as a Quality Control Supervisor, Senior Research Associate, and QC Analyst II. Throughout their career, Adam has been involved in various activities such as method development, qualification and validation, technical transfer, and quality control.

Adam Connelly attended UMass Boston, where they obtained a Bachelor's degree in Biochemistry.